experimental allergic encephalomyelitis

The animal disease, experimental allergic encephalomyelitis, has proved a boon to studying multiple sclerosis, a disease not known to occur naturally in any animals except humans.

Experimental autoimmune encephalomyelitis, sometimes Experimental Allergic Encephalomyelitis (EAE) is an animal model of brain inflammation.

Pixantrone has a similar mechanism of action as mitoxantrone on the effector function of lymphomonocyte B and T cells in experimental allergic encephalomyelitis but with lower cardiotoxicity.

Experimental allergic encephalomyelitis (EAE) is an animal model of CNS inflammation and demyelination frequently used to investigate potential MS treatments.

This form of treatment for the disease has been tested in many studies of experimental allergic encephalomyelitis, the animal model of MS, and several published and on-going phase I and phase II human trials.

For several decades, Sela have been interested in the possibility of fighting the autoimmune disease, experimental allergic encephalomyelitis (EAE) with synthetic analogs of the molecules in the myelin sheath of the brain which are capable of provoking the disease.

Moreover, the administration of UA is therapeutic in experimental allergic encephalomyelitis (EAE), an animal model of MS." In sum, while the mechanism of UA as an antioxidant is well-supported, the claim that its levels affect MS risk is still controversial, and requires more research.